13F Data
13F filer · CIK 872589

REGENERON PHARMACEUTICALS, INC.

TARRYTOWN, NY · filing since Q4 2024 · last filing Nov 5, 2026
Reported value
$179.6M
+$2.4M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q2 2026

No new or increased positions this quarter.

Biggest sells vs Q2 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $1.1BQ1 2025: $1.2BQ2 2025: $1.5BQ3 2025: $700.4MQ4 2025: $33.8MQ1 2026: $47.9MQ2 2026: $177.2MQ3 2026: $179.6M
Q4 2024Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1Parabilis Medicines, Inc.COMMON STOCK4,166,666$134.5M74.90%
2Intellia Therapeutics, Inc.COMMON STOCK3,702,995$44.7M24.86%
3Adicet Bio, Inc.COMMON STOCK60,511$432.0K0.24%